CORCEPT THERAPEUTICS INC (CORT)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About CORCEPT THERAPEUTICS INC
Corcept Therapeutics Incorporated (NASDAQ: CORT) is a U.S. pharmaceutical company focused on cortisol modulation. Its business today centers on Korlym, an oral medication taken once daily, and it generated $761.4 million of revenue in FY2025 from operations in the healthcare sector.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
CORCEPT THERAPEUTICS INC's Technical Indicators Summary
The stock is trading at 112.5 and shows a decisive bullish profile, supported by a strong ADX reading around 44 which indicates a robust trend. Momentum measures and the MACD both signal buy, while short- and medium-term moving averages sit well above the 200-day level, underscoring broad upside alignment. Volatility is moderate with an ATR near 4.5%, and classic pivot levels are essentially neutral near the current price. However, on‑balance volume is lagging, suggesting limited volume confirmation for the advance. Technical takeaway: Strong buy bias confirmed by trend and moving-average alignment, but watch the volume divergence.
| Indicator | Value |
|---|---|
RSI (14) | 64.00 |
Stochastic %K (14, 3, 3) | 70.98 |
CCI (20) | 67.54 |
WPR (14) | -30.15 |
Momentum (10) | 19.55 |
MFI | 53.09 |
MACD Level (12, 26) | 6.93 |
Bollinger Bands | $81.95 - $123.26 |
ATR (14) | $4.98 (4.43%) |
ADX (14) | 44.05 |
OBV | 33,290,601 |
Classic Pivot Point | $112.74 |
Fibonacci Pivot Point | $112.74 |
Exponential Moving Averages | $72.84 - $109.41(5 indicators) |
Simple Moving Averages | $63.22 - $112.34(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
A modest gain keeps CORT 0.75% above its prior close of 111.86. Sector-level price action is largely a non-event (0.25%), shifting attention to idiosyncratic factors. CORT sees insider selling of $418,561 by Corcept's chief development officer alongside an upgraded 2026 revenue outlook and buybacks.
Trading Volume
Below 10d avg (1.4M)
130.2K
vs S&P 500 Today
Outperforming Market
+0.50%
52-Week Position
Upper range
89.8%
Updated: August 12, 2026 at 16:32 UTC